In this scenario, the possibility of connecting TRAP1 chaperone activity with oncogenic transduction pathways, such as hyperactive Ras/ERK signaling, opens new avenues to elucidate in which tumor types and stages the metabolic rewiring prompted by TRAP1 is pivotal for neoplastic progression. The gene discussed is TRAP1; the disease is neoplasm.